| Ad Title: |
Cervical Cancer |
| Study Title: |
COG-219: A Phase III, Randomized Trial of Weekly Cisplatin and Radiation Versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIB, IIIB and IVA Cervical Carcinoma Limited to the Pelvis |
| Protocol Number: |
052006-062 |
| Department(s) involved in the Study: |
Obstetrics & Gynecology, Simmons Comprehensive Cancer Center
|
| Purpose of the Study: |
To determine if combining tirapazamine (TPZ) with cisplatin during radiation therapy increases progression-free survival compared with cisplatin and radiation therapy. |
| Participant Eligibility: |
Call Study Coordinator for eligibilty. |
| Disease/Condition Under Study: |
Cervical Cancer |
| Cancer Related Study: |
Yes
|
| Study Drug(s): |
Cisplatin (Platinol)
|
| Study Device(s): |
|
| Study Doctor: |
Dr. David Miller |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
Parkland Memorial Hospital
|
Yes
|
|
Aston Ambulatory Care Center
|
Yes
|
|
UT Southwestern Moncrief Cancer Center, University of Texas Southwestern Medical Center
|
Yes
|
|
| Contact Phone: |
214_648_6753 |
| Email: |
Paula.Honea@utsouthwestern.edu |
| Other Information: |
This is a Gynecologic Oncology Group sponsored trial. |
| Website Keywords: |
Gyn Oncology, Gynecology, Women's Health
|
| Medical Keywords: |
cancer
|
